GAM
IDXX icon

Generali Asset Management’s Idexx Laboratories IDXX Stock Holding History

Generali Asset Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.08M Sell
5,860
-1,877
-24% -$1.05M 0.06% 246
2026
Q1 		$4.35M Buy
7,737
+945
+14% +$606K 0.09% 201
2025
Q4 		$4.59M Sell
6,792
-604
-8% -$411K 0.09% 198
2025
Q3 		$4.73M Sell
7,396
-31
-0.4% -$18.8K 0.1% 185
2025
Q2 		$3.98M Sell
7,427
-1,959
-21% -$937K 0.09% 205
2025
Q1 		$3.94M Sell
9,386
-1,695
-15% -$736K 0.1% 204
2024
Q4 		$4.58M Buy
+11,081
New +$4.86M 0.12% 175

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Generali Asset Management's IDXX Position: Q2 2026 in Review

Generali Asset Management reduced its Idexx Laboratories (IDXX) stake by 24% in Q2 2026, selling an estimated $1.05M and leaving 5,860 shares worth $3.08M. The position accounts for 0.06% of the portfolio, ranked #246.

Generali Asset Management first reported a position in IDXX in Q4 2024 and has held it in 7 quarters since. The position peaked at $4.73M in Q3 2025. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Generali Asset Management held 5,860 shares of Idexx Laboratories worth $3.08M as of Q2 2026.
  • Generali Asset Management sold 1,877 Idexx Laboratories shares in Q2 2026, an estimated $1.05M.
  • Idexx Laboratories made up 0.06% of Generali Asset Management's portfolio in Q2 2026, its #246 holding.
  • Generali Asset Management first reported a position in Idexx Laboratories in Q4 2024 and has held it in 7 quarters since.
  • Generali Asset Management's Idexx Laboratories position peaked at $4.73M in Q3 2025.
  • 1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Generali Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.